Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07298291 · ClinicalTrials.gov registry record · NA
Ocular Proteomics Testing In Chronic Atrophy
A NA study of Age-Related (Dry) Macular Degeneration, sponsored by ClinOmicsAI.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07298291: Recruiting NA study of Age-Related (Dry) Macular Degeneration, sponsored by ClinOmicsAI.
NCT07298291 is a NA study of Age-Related (Dry) Macular Degeneration that is actively recruiting participants, run by ClinOmicsAI. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07298291, a NA study of Age-Related (Dry) Macular Degeneration, is actively recruiting participants, sponsored by ClinOmicsAI.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Study to evaluate the safety of routine diagnostic anterior chamber paracentesis (ACP) for proteomic profiling in patients with geographic atrophy (GA)
Primary Outcome
Incidence of Treatment-Emergent Adverse Events
Conditions Studied
Interventions
- PROCEDURE AC Tap (anterior chamber paracenthesis)
Study Locations (1)
Pennsylvania
- Erie Retina Research - Erie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-30 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT07298291 shows while recruiting
NCT07298291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Age-Related (Dry) Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which AC Tap (anterior chamber paracenthesis) is the first listed.
NCT07298291 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07298291 about?
NCT07298291 is a clinical study titled "Ocular Proteomics Testing In Chronic Atrophy". Study to evaluate the safety of routine diagnostic anterior chamber paracentesis (ACP) for proteomic profiling in patients with geographic atrophy (GA)
What is the current status of trial NCT07298291?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-30. Estimated completion is 2026-07-30.
What conditions does trial NCT07298291 study?
This clinical trial studies the following conditions: Age-Related (Dry) Macular Degeneration.
What interventions are being tested in trial NCT07298291?
The interventions under investigation include: AC Tap (anterior chamber paracenthesis) (PROCEDURE).
Who is sponsoring clinical trial NCT07298291?
This trial is sponsored by ClinOmicsAI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07298291 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-Related (Dry) Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07298291's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI